Cargando…

Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights

An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Foligné, Benoît, Plé, Coline, Titécat, Marie, Dendooven, Arnaud, Pagny, Aurélien, Daniel, Catherine, Singer, Elisabeth, Pottier, Muriel, Bertin, Benjamin, Neut, Christel, Deplanque, Dominique, Dubuquoy, Laurent, Desreumaux, Pierre, Capron, Monique, Standaert, Annie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627314/
https://www.ncbi.nlm.nih.gov/pubmed/31212833
http://dx.doi.org/10.3390/cells8060577
_version_ 1783434709021229056
author Foligné, Benoît
Plé, Coline
Titécat, Marie
Dendooven, Arnaud
Pagny, Aurélien
Daniel, Catherine
Singer, Elisabeth
Pottier, Muriel
Bertin, Benjamin
Neut, Christel
Deplanque, Dominique
Dubuquoy, Laurent
Desreumaux, Pierre
Capron, Monique
Standaert, Annie
author_facet Foligné, Benoît
Plé, Coline
Titécat, Marie
Dendooven, Arnaud
Pagny, Aurélien
Daniel, Catherine
Singer, Elisabeth
Pottier, Muriel
Bertin, Benjamin
Neut, Christel
Deplanque, Dominique
Dubuquoy, Laurent
Desreumaux, Pierre
Capron, Monique
Standaert, Annie
author_sort Foligné, Benoît
collection PubMed
description An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-inflammatory T-helper 1 (Th1) responses and both T-helper 2 (Th2) and regulatory responses. However, detailed mechanisms explaining how P28GST prevents colitis and promotes gut homeostasis remain unknown. Considering the complex interplay between the adaptive and innate immune system and the intestinal microbiota, we raised the question of the possible role of the microbial ecosystem in the anti-inflammatory effects mediated by the helminth-derived P28GST protein. We first analyzed, by 16S rRNA sequencing, the bacterial profiles of mice fecal microbiota at several time points of the P28GST-immunomodulation period prior to trinitrobenzene sulfonic acid (TNBS)-colitis. The influence of gut microbiota in the P28GST-mediated anti-inflammatory effects was then assessed by fecal microbiota transplantation experiments from P28GST-immunized mice to either conventional or microbiota depleted naïve recipient mice. Finally, the experimental data were supplemented by the temporal fecal microbiota compositions of P28GST-treated Crohn’s disease patients from a pilot clinical study (NCT02281916). The P28GST administration slightly modulated the diversity and composition of mouse fecal microbiota while it significantly reduced experimental colitis in mice. Fecal microbiota transplantation experiments failed to restore the P28GST-induced anti-inflammatory effects. In Crohn’s disease patients, P28GST also induced slight changes in their overall fecal bacterial composition. Collectively, these results provide key elements in both the anti-inflammatory mechanisms and the safe therapeutic use of immunomodulation with such promising helminth-derived molecules.
format Online
Article
Text
id pubmed-6627314
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66273142019-07-23 Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights Foligné, Benoît Plé, Coline Titécat, Marie Dendooven, Arnaud Pagny, Aurélien Daniel, Catherine Singer, Elisabeth Pottier, Muriel Bertin, Benjamin Neut, Christel Deplanque, Dominique Dubuquoy, Laurent Desreumaux, Pierre Capron, Monique Standaert, Annie Cells Article An original immuno-regulatory strategy against inflammatory bowel diseases based on the use of 28 kDa glutathione S-transferase (P28GST), a unique schistosome protein, was recently proposed. Improvement of intestinal inflammation occurs through restoration of the immunological balance between pro-inflammatory T-helper 1 (Th1) responses and both T-helper 2 (Th2) and regulatory responses. However, detailed mechanisms explaining how P28GST prevents colitis and promotes gut homeostasis remain unknown. Considering the complex interplay between the adaptive and innate immune system and the intestinal microbiota, we raised the question of the possible role of the microbial ecosystem in the anti-inflammatory effects mediated by the helminth-derived P28GST protein. We first analyzed, by 16S rRNA sequencing, the bacterial profiles of mice fecal microbiota at several time points of the P28GST-immunomodulation period prior to trinitrobenzene sulfonic acid (TNBS)-colitis. The influence of gut microbiota in the P28GST-mediated anti-inflammatory effects was then assessed by fecal microbiota transplantation experiments from P28GST-immunized mice to either conventional or microbiota depleted naïve recipient mice. Finally, the experimental data were supplemented by the temporal fecal microbiota compositions of P28GST-treated Crohn’s disease patients from a pilot clinical study (NCT02281916). The P28GST administration slightly modulated the diversity and composition of mouse fecal microbiota while it significantly reduced experimental colitis in mice. Fecal microbiota transplantation experiments failed to restore the P28GST-induced anti-inflammatory effects. In Crohn’s disease patients, P28GST also induced slight changes in their overall fecal bacterial composition. Collectively, these results provide key elements in both the anti-inflammatory mechanisms and the safe therapeutic use of immunomodulation with such promising helminth-derived molecules. MDPI 2019-06-12 /pmc/articles/PMC6627314/ /pubmed/31212833 http://dx.doi.org/10.3390/cells8060577 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Foligné, Benoît
Plé, Coline
Titécat, Marie
Dendooven, Arnaud
Pagny, Aurélien
Daniel, Catherine
Singer, Elisabeth
Pottier, Muriel
Bertin, Benjamin
Neut, Christel
Deplanque, Dominique
Dubuquoy, Laurent
Desreumaux, Pierre
Capron, Monique
Standaert, Annie
Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title_full Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title_fullStr Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title_full_unstemmed Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title_short Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights
title_sort contribution of the gut microbiota in p28gst-mediated anti-inflammatory effects: experimental and clinical insights
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627314/
https://www.ncbi.nlm.nih.gov/pubmed/31212833
http://dx.doi.org/10.3390/cells8060577
work_keys_str_mv AT folignebenoit contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT plecoline contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT titecatmarie contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT dendoovenarnaud contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT pagnyaurelien contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT danielcatherine contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT singerelisabeth contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT pottiermuriel contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT bertinbenjamin contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT neutchristel contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT deplanquedominique contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT dubuquoylaurent contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT desreumauxpierre contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT capronmonique contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights
AT standaertannie contributionofthegutmicrobiotainp28gstmediatedantiinflammatoryeffectsexperimentalandclinicalinsights